We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

261 hedge funds and large institutions have $535M invested in ARK Genomic Revolution ETF in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 93 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.42% more ownership

Funds ownership: 37.22% → 41.64% (+4.4%)

8% less funds holding

Funds holding: 284 → 261 (-23)

12% less capital invested

Capital invested by funds: $609M → $535M (-$74.2M)

38% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 47

41% less call options, than puts

Call options by funds: $98.4M | Put options by funds: $167M

42% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 93

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
261
Holders Change
-23
Holders Change %
-8.1%
% of All Funds
3.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
54
Reduced
93
Closed
47
Calls
$98.4M
Puts
$167M
Net Calls
-$68.5M
Net Calls Change
+$2.49M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$28.4M
2
Bank of America
Bank of America
North Carolina
+$15.3M
3
Goldman Sachs
Goldman Sachs
New York
+$14.1M
4
UBS Group
UBS Group
Switzerland
+$12.1M
5
GS
GTS Securities
New York
+$4.28M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$10.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$7.45M
3
LC
Longitude (Cayman)
Cayman Islands
-$2.5M
4
Two Sigma Investments
Two Sigma Investments
New York
-$2.49M
5
Citigroup
Citigroup
New York
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
ATPW
201
Ashton Thomas Private Wealth
Arizona
$4.11K +$4.42K +175 New
ADL
202
Asset Dedication LLC
California
$4.09K – – –
DMIC
203
Dixon Mitchell Investment Counsel
British Columbia, Canada
$3.99K – – –
BBPWM
204
Blue Bell Private Wealth Management
Pennsylvania
$3.67K +$1.01K +40 +34%
PTC
205
Private Trust Company
Ohio
$3.52K – – –
PPA
206
Painted Porch Advisors
California
$3.52K +$3.79K +150 New
NCM
207
Northwest Capital Management
Oregon
$3.5K – – –
S
208
Sachetta
Massachusetts
$3.29K – – –
SS
209
Sunbelt Securities
Texas
$3.15K -$1.51K -60 -31%
HI
210
Harbour Investments
Wisconsin
$2.68K -$909 -36 -24%
S
211
Syntrinsic
Colorado
$2.51K – – –
VWM
212
Venturi Wealth Management
Texas
$2.35K -$984 -39 -28%
CHA
213
Carmichael Hill & Associates
Maryland
$2.35K – – –
HNB
214
Hilltop National Bank
Wyoming
$2.35K – – –
SIC
215
SJS Investment Consulting
Ohio
$2.35K +$2.52K +100 New
RFA
216
Register Financial Advisors
Georgia
$2.23K – – –
HWA
217
HHM Wealth Advisors
Tennessee
$2.11K – – –
CIA
218
Cape Investment Advisory
Georgia
$2.11K – – –
CAL
219
Capital Analysts LLC
Pennsylvania
$2K – – –
PP
220
PrairieView Partners
Minnesota
$2K – – –
ST
221
Smithfield Trust
Pennsylvania
$2K – – –
WWM
222
Wolff Wiese Magana
California
$2K – – –
CFO
223
CVA Family Office
Colorado
$1.71K – – –
PCMC
224
Planning Capital Management Corporation
Pennsylvania
$1.64K +$1.77K +70 New
TAM
225
Tucker Asset Management
Colorado
$1.57K +$505 +20 +43%
7 8
9
10 11

ARKG Hedge Fund Activity: Q2 2024 in Review

261 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2024, worth a combined $535M — down 12% from $609M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of ARKG and 29 opened new positions — a net loss of 18 holders — while 93 trimmed existing stakes and 54 added.

The largest buyer was JP Morgan Chase, adding an estimated $28.4M. The largest seller was Morgan Stanley, cutting an estimated $10.5M.

  • 261 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2024, down from 284 in Q1 2024.
  • Funds reported $535M of ARK Genomic Revolution ETF stock for Q2 2024, down 12% quarter-over-quarter.
  • 29 funds opened new ARK Genomic Revolution ETF positions in Q2 2024 and 47 closed out, a net change of -18 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q2 2024 was JP Morgan Chase, an estimated $28.4M added.
  • The largest ARK Genomic Revolution ETF seller in Q2 2024 was Morgan Stanley, an estimated $10.5M sold.

Based on aggregated 13F filings for Q2 2024.